Antineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsDoxorubicinAntineoplastic Agents, PhytogenicCisplatinAntineoplastic Agents, AlkylatingAntibiotics, AntineoplasticPaclitaxelDrug Screening Assays, AntitumorNeoplasmsChemotherapy, AdjuvantCell Line, TumorLeukemia P388Drug SynergismDrug Resistance, NeoplasmAntimetabolites, AntineoplasticEtoposideDose-Response Relationship, DrugDrug Administration ScheduleApoptosisCyclophosphamideAmaryllidaceae AlkaloidsLung NeoplasmsCell SurvivalCombined Modality TherapyEllipticinesNarcissusTumor Cells, CulturedBibenzylsTreatment OutcomeBreast NeoplasmsTaxoidsDeoxycytidineFluorouracilXenograft Model Antitumor AssaysTime FactorsThiadiazinesBryostatinsAdministration, OralBleomycinMethotrexateAncitabineCell ProliferationDacarbazineGalliumMice, Nude6-MercaptopurineDepsipeptidesCell CycleDaunorubicinEpothilonesCarcinoma, Non-Small-Cell LungAminoacridinesMolecular StructureSarcoma 180Drug Delivery SystemsCamptothecinDrug EvaluationLeukemia L1210LactonesProdrugsDrug Evaluation, PreclinicalAntibodies, MonoclonalNeoadjuvant TherapyOvarian NeoplasmsClinical Trials as TopicCell DivisionDisease-Free SurvivalMice, SCIDSurvival AnalysisNeoplasms, ExperimentalDrug ResistanceDrug InteractionsCaspase 3Neoplasm StagingSurvival RateEnzyme InhibitorsPrognosisNeoplasm TransplantationVinblastineCarboplatinColonic NeoplasmsMacrolidesStilbenesInjections, IntravenousBiotransformationLeukemiaOrganoplatinum CompoundsIfosfamideCytarabineInfusions, IntravenousHL-60 CellsIsoquinolinesInduction ChemotherapyRNA, MessengerNeoplasm Recurrence, LocalKineticsAnthracyclinesDNA DamageVincristine